We are live on ! Find out more
ISPC icon

iSpecimen
ISPC

4 hedge funds and large institutions have $94.9K invested in iSpecimen in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

2.17% less ownership

Funds ownership: 5.9% → 3.72% (-2.2%)

33% less funds holding

Funds holding: 6 → 4 (-2)

48% less capital invested

Capital invested by funds: $183K → $94.9K (-$88K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
+$90.9K
2
UBS Group
UBS Group
Switzerland
+$39.5K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$103K
2
FIA
FNY Investment Advisers
New York
-$54K
3
TRCT
Tower Research Capital (TRC)
New York
-$4.34K
4
Bank of America
Bank of America
North Carolina
-$167

ISPC Hedge Fund Activity: Q4 2024 in Review

4 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q4 2024, worth a combined $94.9K — down 48% from $183K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ISPC and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $90.9K. The largest seller was Jane Street, exiting entirely with an estimated $103K sold.

  • 4 institutional investors held iSpecimen (ISPC) as of Q4 2024, down from 6 in Q3 2024.
  • Funds reported $94.9K of iSpecimen stock for Q4 2024, down 48% quarter-over-quarter.
  • 1 fund opened new iSpecimen positions in Q4 2024 and 3 closed out, a net change of -2 holders.
  • The largest iSpecimen buyer in Q4 2024 was Bridgeway Capital Management, an estimated $90.9K added.
  • The largest iSpecimen seller in Q4 2024 was Jane Street, an estimated $103K sold.

Based on aggregated 13F filings for Q4 2024.